PO.TB04.07 · 肿瘤生物学
建立反映骨微环境的骨肉瘤类器官模型
Establishing an osteosarcoma organoid model reflecting the bone microenvironment
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
骨肉瘤是儿童和青少年中最常见的原发性恶性骨肿瘤,通常在骨骼快速生长期间发生于长骨的干骺端。转移性或复发性疾病的生存率仍然很低,而大多数体外研究仍依赖于无法重现矿化基质、基质细胞以及基质结合生长因子(这些因素在骨中塑造骨肉瘤行为)的二维塑料培养。为弥补这一空白,我们使用Saos-2成骨细胞性骨肉瘤细胞建立了一个逐步的骨仿生系统。脱矿骨基质(DBM)作为骨基质来源生长因子(DBM-DGF)的确定来源,包括TGF-beta、BMPs和IGF-1等生长因子,它们共同发挥协同作用。新鲜的人骨碎片提供了一种更完整的骨替代物,具有天然的矿化基质、基质来源因子和常驻骨细胞。在第一层级中,Saos-2细胞用经过预筛选并按成骨诱导活性分组的基质来源生长因子制剂处理。通过MTT实验测量增殖。Saos-2细胞在各DBM-DGF组中显示出梯度性的增殖增加,活性最高的制剂产生最强的增殖反应。这些发现表明,DBM效力直接影响骨基质来源信号的促生长强度,可用于近似模拟"年轻的"、增殖性更强、富含生长因子的骨与更"衰老的"、生长因子贫乏的骨。在第二层级中,将来自骨基质来源基质细胞的条件培养基应用于Saos-2培养,以模拟旁分泌共培养,并测试基质分泌因子如何调控增殖、分化和迁移。在第三层级中,将新鲜人骨碎片与Saos-2细胞在三维中结合,使肿瘤细胞同时经历完整的矿化基质、基质结合生长因子和常驻骨细胞,创造出一个类骨的微环境。这一分层平台直接比较了孤立的基质来源信号与结构和细胞复杂的骨替代物,为研究肿瘤-骨相互作用、骨环境的年龄相关变化以及骨肉瘤候选疗法的临床前测试提供了一个实用、更具生理相关性的模型。
查看英文原文 English abstract
Osteosarcoma is the most common primary malignant bone tumor in children and young adults and usually arises in the metaphyses of long bones during periods of rapid skeletal growth. Survival for metastatic or relapsed disease remains poor, and most in vitro studies still rely on two-dimensional plastic cultures that do not reproduce the mineralized matrix, stromal cells, and matrix-bound growth factors that shape osteosarcoma behavior in bone.To address this gap, we established a stepwise bone-mimetic system using Saos-2 osteoblastic osteosarcoma cells. Demineralized bone matrix (DBM) serves as a defined source of bone-matrix-derived growth factors (DBM-DGF), including growth factors such as TGF-beta, BMPs, and IGF-1, which act together in a combined effect. Fresh human bone chips provide a more complete bone surrogate with native mineralized matrix, matrix-derived factors, and resident bone cells. In tier 1, Saos-2 cells were treated with matrix-derived growth factor preparations that had been prescreened and grouped by osteoinductive activity. Proliferation was measured by MTT assay. Saos-2 cells showed a graded increase in proliferation across DBM-DGF groups, with the highest-activity preparations producing the strongest proliferative response. These findings indicate that DBM potency directly influences the growth-promoting strength of bone-matrix-derived signals and can be used to approximate “young,” more proliferative, growth-factor-rich bone versus more “aged,” growth-factor-poor bone.In tier 2, conditioned medium from bone-matrix-derived stromal cells is applied to Saos-2 cultures to model paracrine co-culture and test how stromal secreted factors regulate proliferation, differentiation, and migration. In tier 3, fresh human bone chips are combined with Saos-2 cells in three dimensions so that tumor cells experience intact mineralized matrix, matrix-bound growth factors, and resident bone cells at the same time, creating a bone-like microenvironment. This tiered platform directly compares isolated matrix-derived signals with a structurally and cellularly complex bone surrogate and provides a practical, more physiologically relevant model for studying tumor-bone interactions, age-related changes in the bone environment, and for preclinical testing of candidate therapies in osteosarcoma.
利益披露 Disclosure
X. Li, None..
Z. Yang, None..
B. Hoang, None..
B. Han, None.